The Future of Body Contouring has Arrived.
Introducing the AYON™ Body Contouring System
The first FDA cleared all-in-one platform for the aesthetic surgical suite, combining precision, versatility, and innovation.
A New Standard in Surgical Care
The official agent for the AYON device in Iraq
A new revolution in body sculpting and liposuction with advanced technology
- 🔹 Higher accuracy - faster recovery time - natural and ideal results
- 🔹 The perfect solution for tightening and body contouring
AYON is a groundbreaking, surgeon-designed body contouring system that combines precision, versatility, and innovation in an all-in-one platform. It seamlessly integrates fat removal, closed loop contouring, tissue contraction, and electrosurgical capabilities, empowering surgeons to deliver the most comprehensive body contouring treatments for patients.
With advanced features like LIFT Technology for real-time adjustments and Renuvion for enhanced tissue contraction, AYON sets a new standard in surgical care, streamlining procedures and maximizing patient outcomes. Backed by Apyx Medical’s expertise and evidence-based design, AYON delivers consistent, reliable performance and an unmatched return on investment. As the first of its kind, AYON is revolutionizing body contouring and shaping the future of aesthetic surgery.
Revolutionary Treatments
This initial 510(k) clearance for AYON covers a wide variety of aesthetic treatments. The Company plans to expand the cleared indications for AYON, to include power liposuction, with an additional 510(k) submission later this year.
Trusted by Leading Surgeons
"Dr. Constantino Mendieta is among the first in South Florida to bring this revolutionary technology to his patients."
Dr. Constantino Mendieta
South Florida
"Dr. Bharat Shah is the first in the state to bring AYON to his patients, continuing to push innovation forward in the region."
Dr. Bharat Shah
Shah Plastic Surgery
"AYON is like beyond the R2D2 of our time,” says Dr. Paul Vanek, the first surgeon in Ohio to bring AYON to his patients, raising the bar for surgical innovation in the state."
Dr. Paul Vanek
Ohio
Our Videos on Instagram
Explore Our Technologies
Discover our other innovative devices.
Forward-Looking Statements
Certain matters discussed in this release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved.
All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including but not to, projections of net revenue, margins, expenses, net earnings, net earnings per share, or other financial items; projections or assumptions concerning the possible receipt by the Company of any regulatory approvals from any government agency or instrumentality including but not limited to the U.S. Food and Drug Administration (the “FDA”), supply chain disruptions, component shortages, manufacturing disruptions or logistics challenges; or macroeconomic or geopolitical matters and the impact of those matters on the Company’s financial performance.
Forward-looking statements and information are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause the Company’s actual results to differ materially and that could impact the Company and the statements contained in this release include but are not limited to risks, uncertainties and assumptions relating to the regulatory environment in which the Company is subject to, including the Company’s ability to gain requisite approvals for its products from the FDA and other governmental and regulatory bodies, both domestically and internationally; sudden or extreme volatility in commodity prices and availability, including supply chain disruptions; changes in general economic, business or demographic conditions or trends; changes in and effects of the geopolitical environment; liabilities and costs which the Company may incur from pending or threatened litigations, claims, disputes or investigations; and other risks that are described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and the Company’s other filings with the Securities and Exchange Commission. For forward-looking statements in this release, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.
